{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T17:21:40Z","timestamp":1791220900150,"version":"4.1.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T00:00:00Z","timestamp":1746403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T00:00:00Z","timestamp":1746403200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Australian National Health and Medical Research Council","award":["APP1194051"],"award-info":[{"award-number":["APP1194051"]}]},{"DOI":"10.13039\/501100003579","name":"University of Toronto","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003579","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100009812","name":"Princess Margaret Cancer Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009812","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1007\/s10549-025-07700-y","type":"journal-article","created":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T05:54:07Z","timestamp":1746424447000},"page":"1-12","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Chronic skin toxicities in breast cancer survivors: a systematic review and meta-analysis of radiotherapy techniques"],"prefix":"10.1007","volume":"212","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4696-9434","authenticated-orcid":false,"given":"Shing Fung","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry C. Y.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jolien","family":"Robijns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen Lowell B.","family":"Ciocon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula Elaine Diniz","family":"dos Reis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarina","family":"Sadeghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muna","family":"Al-Khaifi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mami","family":"Ogita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian W.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agata","family":"Rembielak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Livesey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Chong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihui Amy","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Trombetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wee Yao","family":"Koh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiat Horng","family":"Leong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gustavo N.","family":"Marta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierluigi","family":"Bonomo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viola","family":"Salvestrini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vassilios","family":"Vassiliou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pradnya","family":"Chopade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Partha","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cindy","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie Ryan","family":"Wolf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corina","family":"van den Hurk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond J.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Jefford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Chow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer Yin Yee","family":"Kwan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of\u00a0the Multinational Association of Supportive Care in Cancer (MASCC) Oncodermatology\u00a0and, Survivorship Study Groups","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,5]]},"reference":[{"key":"7700_CR1","doi-asserted-by":"publisher","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I (2024). Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer J Clin. 2024; 74(3):229\u2013263. https:\/\/doi.org\/10.3322\/caac.21834.","DOI":"10.3322\/caac.21834"},{"key":"7700_CR2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2022-074684","volume":"381","author":"C Taylor","year":"2023","unstructured":"Taylor C, McGale P, Probert J, Broggio J, Charman J, Darby SC et al (2023) Breast cancer mortality in 500000 women with early invasive breast cancer diagnosed in England, 1993\u20132015: population based observational cohort study. BMJ 381:e074684","journal-title":"BMJ"},{"key":"7700_CR3","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1016\/S0140-6736(11)61629-2","volume":"378","author":"S Darby","year":"2011","unstructured":"Darby S, McGale P, Correa C, Taylor C, Arriagada R, Clarke M et al (2011) Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials. Lancet 378:1707\u20131716","journal-title":"Lancet"},{"key":"7700_CR4","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1016\/S0140-6736(14)60488-8","volume":"383","author":"P McGale","year":"2014","unstructured":"McGale P, Taylor C, Correa C, Cutter D, Duane F, Ewertz M et al (2014) Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials. Lancet 383:2127\u20132135","journal-title":"Lancet"},{"key":"7700_CR5","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/S0959-8049(97)00312-2","volume":"34","author":"D Curran","year":"1998","unstructured":"Curran D, van Dongen JP, Aaronson NK, Kiebert G, Fentiman IS, Mignolet F et al (1998) Quality of life of early-stage breast cancer patients treated with radical mastectomy or breast-conserving procedures: results of EORTC Trial 10801. The European Organization for Research and Treatment of Cancer (EORTC), Breast Cancer Co-operative Group (BCCG). Eur J Cancer. 34:307\u2013314","journal-title":"Eur J Cancer."},{"key":"7700_CR6","doi-asserted-by":"publisher","first-page":"6745954","DOI":"10.1155\/2022\/6745954","volume":"2022","author":"MCT Batenburg","year":"2022","unstructured":"Batenburg MCT, Bartels M, Maarse W, Witkamp A, Verkooijen HM, van den Bongard H (2022) Factors associated with late local radiation toxicity after post-operative breast irradiation. Breast J 2022:6745954","journal-title":"Breast J"},{"key":"7700_CR7","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.ijwd.2020.07.015","volume":"6","author":"JY Ramseier","year":"2020","unstructured":"Ramseier JY, Ferreira MN, Leventhal JS (2020) Dermatologic toxicities associated with radiation therapy in women with breast cancer. Int J Womens Dermatol 6:349\u2013356","journal-title":"Int J Womens Dermatol"},{"key":"7700_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.738851","volume":"11","author":"Y Xie","year":"2021","unstructured":"Xie Y, Wang Q, Hu T, Chen R, Wang J, Chang H et al (2021) Risk factors related to acute radiation dermatitis in breast cancer patients after radiotherapy: a systematic review and meta-analysis. Front Oncol 11:738851","journal-title":"Front Oncol"},{"key":"7700_CR9","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.abd.2023.01.004","volume":"99","author":"LG Cavalcante","year":"2024","unstructured":"Cavalcante LG, Domingues RAR, Junior BdO, Fernandes MAR, Pessoa EC, Abbade LPF (2024) Incidence of radiodermatitis and factors associated with its severity in women with breast cancer: a cohort study. Anais Brasileiros de Dermatol 99:57\u201365","journal-title":"Anais Brasileiros de Dermatol"},{"key":"7700_CR10","volume":"15","author":"P Prasun","year":"2023","unstructured":"Prasun P, Kharade V, Pal V, Gupta M, Das S, Pasricha R (2023) Dosimetric comparison of hypofractionated regimen in breast cancer using two different techniques: intensity-modulated radiation therapy (IMRT) and volumetric-modulated arc therapy (VMAT). Cureus 15:e38045","journal-title":"Cureus"},{"key":"7700_CR11","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/S1470-2045(08)70098-6","volume":"9","author":"L Veldeman","year":"2008","unstructured":"Veldeman L, Madani I, Hulstaert F, De Meerleer G, Mareel M, De Neve W (2008) Evidence behind use of intensity-modulated radiotherapy: a systematic review of comparative clinical studies. Lancet Oncol 9:367\u2013375","journal-title":"Lancet Oncol"},{"key":"7700_CR12","first-page":"e31860","volume":"14","author":"A Ahmad","year":"2022","unstructured":"Ahmad A, Das S, Kharade V, Gupta M, Pandey VP, et al (2022) Dosimetric study comparing 3D conformal radiotherapy (3D-CRT), intensity modulated radiotherapy (IMRT) and volumetric modulated arc therapy (VMAT) in hypofractionated one-week radiotherapy regimen in breast cancer. Cureus 14:e31860","journal-title":"Cureus"},{"key":"7700_CR13","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/j.clon.2012.05.003","volume":"24","author":"I Dayes","year":"2012","unstructured":"Dayes I, Rumble RB, Bowen J, Dixon P, Warde P (2012) Intensity-modulated radiotherapy in the treatment of breast cancer. Clin Oncol (R Coll Radiol) 24:488\u2013498","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"7700_CR14","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/s13643-016-0384-4","volume":"5","author":"M Ouzzani","year":"2016","unstructured":"Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A (2016) Rayyan-a web and mobile app for systematic reviews. Syst Rev 5:210","journal-title":"Syst Rev"},{"key":"7700_CR15","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.i4919","volume":"355","author":"JA Sterne","year":"2016","unstructured":"Sterne JA, Hern\u00e1n MA, Reeves BC, Savovi\u0107 J, Berkman ND, Viswanathan M et al (2016) ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ 355:i4919","journal-title":"BMJ"},{"key":"7700_CR16","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.d5928","volume":"343","author":"JPT Higgins","year":"2011","unstructured":"Higgins JPT, Altman DG, G\u00f8tzsche PC, J\u00fcni P, Moher D, Oxman AD et al (2011) The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials. BMJ 343:d5928","journal-title":"BMJ"},{"key":"7700_CR17","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1378\/chest.129.1.174","volume":"129","author":"G Guyatt","year":"2006","unstructured":"Guyatt G, Gutterman D, Baumann MH, Addrizzo-Harris D, Hylek EM, Phillips B et al (2006) Grading strength of recommendations and quality of evidence in clinical guidelines: report from an American college of chest physicians task force. Chest 129:174\u2013181","journal-title":"Chest"},{"key":"7700_CR18","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/1053-4296(92)90013-B","volume":"2","author":"AS Lichter","year":"1992","unstructured":"Lichter AS, Fraass BA, Yanke B (1992) Treatment techniques in the conservative management of breast cancer. Semin Radiat Oncol 2:94\u2013106","journal-title":"Semin Radiat Oncol"},{"key":"7700_CR19","doi-asserted-by":"publisher","first-page":"349","DOI":"10.4048\/jbc.2022.25.e37","volume":"25","author":"JS Chang","year":"2022","unstructured":"Chang JS, Chang JH, Kim N, Kim YB, Shin KH, Kim K (2022) Intensity modulated radiotherapy and volumetric modulated arc therapy in the treatment of breast cancer: an updated review. J Breast Cancer 25:349\u2013365","journal-title":"J Breast Cancer"},{"key":"7700_CR20","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.jmir.2010.11.005","volume":"42","author":"C Elith","year":"2011","unstructured":"Elith C, Dempsey SE, Findlay N, Warren-Forward HM (2011) An introduction to the Intensity-modulated Radiation Therapy (IMRT) techniques, yomotherapy, and VMAT. J Med Imaging Radiat Sci 42:37\u201343","journal-title":"J Med Imaging Radiat Sci"},{"key":"7700_CR21","unstructured":"National Cancer Institute. Common Terminology Criteria for Adverse Events (Version 5.0). National Cancer Institute, National Institutes of Health."},{"key":"7700_CR22","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1016\/0360-3016(95)00060-C","volume":"31","author":"JD Cox","year":"1995","unstructured":"Cox JD, Stetz J, Pajak TF (1995) Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 31:1341\u20131346","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"7700_CR23","doi-asserted-by":"crossref","unstructured":"Pavy JJ, Denekamp J, Letschert J, Littbrand B, Mornex F, Bernier J, et al (1993) EORTC Late Effects Working Group. Late effects toxicity scoring: the SOMA scale. Radiother Oncol 35:11\u201315.","DOI":"10.1016\/0167-8140(95)97448-M"},{"key":"7700_CR24","unstructured":"RevMan. Version 5.4.1. Cochrane; 2023."},{"key":"7700_CR25","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.radonc.2006.12.008","volume":"82","author":"E Donovan","year":"2007","unstructured":"Donovan E, Bleakley N, Denholm E, Evans P, Gothard L, Hanson J et al (2007) Randomised trial of standard 2D radiotherapy (RT) versus intensity modulated radiotherapy (IMRT) in patients prescribed breast radiotherapy. Radiother Oncol 82:254\u2013264","journal-title":"Radiother Oncol"},{"key":"7700_CR26","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1016\/j.ijrobp.2007.02.044","volume":"68","author":"A Harsolia","year":"2007","unstructured":"Harsolia A, Kestin L, Grills I, Wallace M, Jolly S, Jones C et al (2007) Intensity-modulated radiotherapy results in significant decrease in clinical toxicities compared with conventional wedge-based breast radiotherapy. Int J Radiat Oncol Biol Phys 68:1375\u20131380","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"7700_CR27","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1016\/j.clon.2011.04.011","volume":"23","author":"GC Barnett","year":"2011","unstructured":"Barnett GC, Wilkinson JS, Moody AM, Wilson CB, Twyman N, Wishart GC et al (2011) The Cambridge breast intensity-modulated radiotherapy trial: patient- and treatment-related factors that influence late toxicity. Clin Oncol (R Coll Radiol) 23:662\u2013673","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"7700_CR28","doi-asserted-by":"publisher","first-page":"e415","DOI":"10.1016\/j.ijrobp.2011.06.1950","volume":"82","author":"ME Hardee","year":"2012","unstructured":"Hardee ME, Raza S, Becker SJ, Jozsef G, Lymberis SC, Hochman T et al (2012) Prone hypofractionated whole-breast radiotherapy without a boost to the tumor bed: comparable toxicity of IMRT versus a 3D conformal technique. Int J Radiat Oncol Biol Phys 82:e415\u2013e423","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"7700_CR29","doi-asserted-by":"publisher","first-page":"4488","DOI":"10.1200\/JCO.2013.49.7842","volume":"31","author":"MB Mukesh","year":"2013","unstructured":"Mukesh MB, Barnett GC, Wilkinson JS, Moody AM, Wilson C, Dorling L et al (2013) Randomized controlled trial of intensity-modulated radiotherapy for early breast cancer: 5-year results confirm superior overall cosmesis. J Clin Oncol 31:4488\u20134495","journal-title":"J Clin Oncol"},{"key":"7700_CR30","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.radonc.2014.02.016","volume":"111","author":"MB Mukesh","year":"2014","unstructured":"Mukesh MB, Qian W, Wilkinson JS, Dorling L, Barnett GC, Moody AM et al (2014) Patient reported outcome measures (PROMs) following forward planned field-in field IMRT: results from the Cambridge Breast IMRT trial. Radiother Oncol 111:270\u2013275","journal-title":"Radiother Oncol"},{"key":"7700_CR31","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.radonc.2016.08.021","volume":"121","author":"JP Pignol","year":"2016","unstructured":"Pignol JP, Truong P, Rakovitch E, Sattler MG, Whelan TJ, Olivotto IA (2016) Ten years results of the Canadian breast intensity modulated radiation therapy (IMRT) randomized controlled trial. Radiother Oncol 121:414\u2013419","journal-title":"Radiother Oncol"},{"key":"7700_CR32","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000003113","volume":"95","author":"JF Yang","year":"2016","unstructured":"Yang JF, Lee MS, Lin CS, Chao HL, Chen CM, Lo CH et al (2016) Long-term breast cancer patient outcomes after adjuvant radiotherapy using intensity-modulated radiotherapy or conventional tangential radiotherapy. Medicine (Baltimore) 95:e3113","journal-title":"Medicine (Baltimore)"},{"key":"7700_CR33","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.7150\/jca.51125","volume":"12","author":"Y Zhao","year":"2021","unstructured":"Zhao Y, Zhu J, Zhang X, Wu G, Xu Y, Shen P et al (2021) Integrated IMRT vs segmented 3D-CRT of the chest wall and supraclavicular region for Breast Cancer after modified Radical Mastectomy: an 8-year follow-up. J Cancer 12:1548\u20131554","journal-title":"J Cancer"},{"key":"7700_CR34","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.jaad.2005.08.054","volume":"54","author":"SR Hymes","year":"2006","unstructured":"Hymes SR, Strom EA, Fife C (2006) Radiation dermatitis: clinical presentation, pathophysiology, and treatment 2006. J Am Acad Dermatol 54:28\u201346","journal-title":"J Am Acad Dermatol"},{"key":"7700_CR35","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1007\/s12094-021-02729-z","volume":"24","author":"Y Huang","year":"2022","unstructured":"Huang Y, Sanz J, Rodr\u00edguez N, Duran X, Mart\u00ednez A, Li X et al (2022) Quantitative assessments of late radiation-induced skin and soft tissue toxicity and correlation with RTOG scales and biological equivalent dose in breast cancer. Clin Transl Oncol 24:836\u2013845","journal-title":"Clin Transl Oncol"},{"key":"7700_CR36","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s12885-021-09157-w","volume":"22","author":"M Salas","year":"2022","unstructured":"Salas M, Mordin M, Castro C, Islam Z, Tu N, Hackshaw MD (2022) Health-related quality of life in women with breast cancer: a review of measures. BMC Cancer 22:66","journal-title":"BMC Cancer"},{"key":"7700_CR37","doi-asserted-by":"crossref","unstructured":"Clarijs ME, Thurell J, K\u00fchn F, Uyl-de Groot CA, Hedayati E, Karsten MM, et al (2021) Measuring quality of life using patient-reported outcomes in real-world metastatic breast cancer patients: the need for a standardized approach. Cancers (Basel), p. 13.","DOI":"10.3390\/cancers13102308"},{"key":"7700_CR38","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.jviscsurg.2013.10.001","volume":"151","author":"F Fiteni","year":"2014","unstructured":"Fiteni F, Westeel V, Pivot X, Borg C, Vernerey D, Bonnetain F (2014) Endpoints in cancer clinical trials. J Visc Surg 151:17\u201322","journal-title":"J Visc Surg"},{"key":"7700_CR39","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1016\/j.ijrobp.2009.09.040","volume":"76","author":"SM Bentzen","year":"2010","unstructured":"Bentzen SM, Constine LS, Deasy JO, Eisbruch A, Jackson A, Marks LB et al (2010) Quantitative analyses of normal tissue effects in the clinic (QUANTEC): an introduction to the scientific issues. Int J Radiat Oncol Biol Phys 76:S3-9","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"7700_CR40","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.breast.2022.01.018","volume":"62","author":"GN Marta","year":"2022","unstructured":"Marta GN, Riera R, Pacheco RL, Cabrera Martimbianco AL, Meattini I, Kaidar-Person O et al (2022) Moderately hypofractionated post-operative radiation therapy for breast cancer: systematic review and meta-analysis of randomized clinical trials. Breast 62:84\u201392","journal-title":"Breast"},{"key":"7700_CR41","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.radonc.2016.02.027","volume":"120","author":"AM Brunt","year":"2016","unstructured":"Brunt AM, Wheatley D, Yarnold J, Somaiah N, Kelly S, Harnett A et al (2016) Acute skin toxicity associated with a 1-week schedule of whole breast radiotherapy compared with a standard 3-week regimen delivered in the UK FAST-Forward Trial. Radiother Oncol 120:114\u2013118","journal-title":"Radiother Oncol"},{"key":"7700_CR42","doi-asserted-by":"publisher","first-page":"3261","DOI":"10.1200\/JCO.19.02750","volume":"38","author":"AM Brunt","year":"2020","unstructured":"Brunt AM, Haviland JS, Sydenham M, Agrawal RK, Algurafi H, Alhasso A et al (2020) Ten-year results of FAST: a randomized controlled trial of 5-fraction whole-breast radiotherapy for early breast cancer. J Clin Oncol 38:3261\u20133272","journal-title":"J Clin Oncol"},{"key":"7700_CR43","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/1756-9966-32-80","volume":"32","author":"V Landoni","year":"2013","unstructured":"Landoni V, Giordano C, Marsella A, Saracino B, Petrongari MG, Ferraro AM et al (2013) Evidence from a breast cancer hypofractionated schedule: late skin toxicity assessed by ultrasound. J Exp Clin Cancer Res 32:80","journal-title":"J Exp Clin Cancer Res"},{"key":"7700_CR44","doi-asserted-by":"crossref","unstructured":"Dejonckheere CS, Abramian A, Lindner K, Bachmann A, Layer K, Anzb\u00f6ck T, et al (2023) Objective, clinician- and patient-reported evaluation of late toxicity following adjuvant radiation for early breast cancer: long-term follow-up results of a randomised series. J Clin Med,  p 12.","DOI":"10.3390\/jcm12134212"},{"key":"7700_CR45","doi-asserted-by":"publisher","first-page":"e228","DOI":"10.3747\/co.23.2998","volume":"23","author":"JH Yong","year":"2016","unstructured":"Yong JH, McGowan T, Redmond-Misner R, Beca J, Warde P, Gutierrez E et al (2016) Estimating the costs of intensity-modulated and 3-dimensional conformal radiotherapy in Ontario. Curr Oncol 23:e228\u2013e238","journal-title":"Curr Oncol"},{"key":"7700_CR46","doi-asserted-by":"crossref","unstructured":"Laskar SG, Sinha S, Krishnatry R, Grau C, Mehta M, Agarwal JP (2022) Access to radiation therapy: from local to global and equality to equity. JCO Global Oncology,  e2100358.","DOI":"10.1200\/GO.21.00358"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-025-07700-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10549-025-07700-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-025-07700-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,18]],"date-time":"2025-05-18T07:24:17Z","timestamp":1747553057000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10549-025-07700-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,5]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["7700"],"URL":"https:\/\/doi.org\/10.1007\/s10549-025-07700-y","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,5]]},"assertion":[{"value":"30 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}}]}}